{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:02:27Z","timestamp":1790935347090,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,12,8]],"date-time":"2009-12-08T00:00:00Z","timestamp":1260230400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2009,12,8]],"date-time":"2009-12-08T00:00:00Z","timestamp":1260230400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>We have previously identified a rare subpopulation of variant human mammary epithelial cells (vHMEC) with repressed p16<jats:sup>INK4A<\/jats:sup> that exist in disease-free women yet display premalignant properties, suggesting that they have engaged the process of malignant transformation. In order to gain insight into the molecular alterations required for vHMEC to progress to malignancy, and to characterize the epigenetic events associated with early progression, we examined the effect of oncogenic stress on the behavior of these cells.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>HMEC that express p16<jats:sup>INK4A<\/jats:sup> and vHMEC that do not, were transduced with constitutively active Ha-rasV12 and subsequently exposed to serum to determine whether signals from the cellular microenvironment could cooperate with ras to promote the malignant transformation of vHMEC. Epigenetic alterations were assessed using methylation-specific polymerase chain reaction (PCR).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>vHMEC expressing Ha-rasV12 (vHMEC-ras) bypassed the classic proliferative arrest that has been previously documented in normal fibroblasts following oncogenic stress, and that we also observe here in normal HMEC. Moreover, vHMEC-ras cells exhibited many additional alterations that are observed during progression to malignancy such as the generation of chromosomal abnormalities, upregulation of telomerase activity, immortalization following exposure to serum, and anchorage-independent growth, but they did not form tumors following orthotopic injection <jats:italic>in vivo<\/jats:italic>. Associated with their early progression to malignancy was an increase in the number of genes methylated, two of which (<jats:italic>RASSF1A<\/jats:italic> and <jats:italic>SFRP1<\/jats:italic>) were also methylated in other immortalized mammary cell lines as well as in breast cancer cells and tissues.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>We have characterized a mammary progression model that recapitulates molecular and methylation alterations observed in many breast cancers. Our data suggest that concomitant methylation of <jats:italic>RASSF1A<\/jats:italic> and <jats:italic>SFRP1<\/jats:italic> marks an early event in mammary transformation and may thus have prognostic potential.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/bcr2457","type":"journal-article","created":{"date-parts":[[2009,12,9]],"date-time":"2009-12-09T07:21:07Z","timestamp":1260343267000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Human mammary cancer progression model recapitulates methylation events associated with breast premalignancy"],"prefix":"10.1186","volume":"11","author":[{"given":"Nancy","family":"Dumont","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping G","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahvash","family":"Sigaroudinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shefali S","family":"Nagrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew B","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gertrude C","family":"Buehring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulisa","family":"Turashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Aparicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona L","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen A","family":"Fordyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly M","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thea D","family":"Tlsty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,12,8]]},"reference":[{"key":"2419_CR1","first-page":"4776","volume":"46","author":"C Theillet","year":"1986","unstructured":"Theillet C, Lidereau R, Escot C, Hutzell P, Brunet M, Gest J, Schlom J, Callahan R: Loss of a c-H-ras-1 allele and aggressive human primary breast carcinomas. Cancer Res. 1986, 46: 4776-4781.","journal-title":"Cancer Res"},{"key":"2419_CR2","first-page":"269","volume":"4","author":"DA Spandidos","year":"1984","unstructured":"Spandidos DA, Agnantis NJ: Human malignant tumours of the breast, as compared to their respective normal tissue, have elevated expression of the Harvey ras oncogene. Anticancer Res. 1984, 4: 269-272.","journal-title":"Anticancer Res"},{"key":"2419_CR3","first-page":"59","volume":"79","author":"PH Hand","year":"1987","unstructured":"Hand PH, Vilasi V, Thor A, Ohuchi N, Schlom J: Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas. J Natl Cancer Inst. 1987, 79: 59-65.","journal-title":"J Natl Cancer Inst"},{"key":"2419_CR4","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/ijc.2910430315","volume":"43","author":"F De Biasi","year":"1989","unstructured":"De Biasi F, Del Sal G, Hand PH: Evidence of enhancement of the ras oncogene protein product (p21) in a spectrum of human tumors. Int J Cancer. 1989, 43: 431-435. 10.1002\/ijc.2910430315.","journal-title":"Int J Cancer"},{"key":"2419_CR5","first-page":"2511","volume":"46","author":"N Ohuchi","year":"1986","unstructured":"Ohuchi N, Thor A, Page DL, Hand PH, Halter SA, Schlom J: Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues. Cancer Res. 1986, 46: 2511-2519.","journal-title":"Cancer Res"},{"key":"2419_CR6","doi-asserted-by":"publisher","first-page":"pe14","DOI":"10.1126\/stke.113pe14","volume":"1","author":"X Cheng","year":"2008","unstructured":"Cheng X: Silent assassin: oncogenic ras directs epigenetic inactivation of target genes. Sci Signal. 2008, 1: pe14-10.1126\/stke.113pe14.","journal-title":"Sci Signal"},{"key":"2419_CR7","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1038\/sj.onc.1209386","volume":"25","author":"J Veeck","year":"2006","unstructured":"Veeck J, Niederacher D, An H, Klopocki E, Wiesmann F, Betz B, Galm O, Camara O, Durst M, Kristiansen G, Huszka C, Kn\u00fcchel R, Dahl E: Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis. Oncogene. 2006, 25: 3479-3488. 10.1038\/sj.onc.1209386.","journal-title":"Oncogene"},{"key":"2419_CR8","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.humpath.2006.04.013","volume":"37","author":"K Munot","year":"2006","unstructured":"Munot K, Bell SM, Lane S, Horgan K, Hanby AM, Speirs V: Pattern of expression of genes linked to epigenetic silencing in human breast cancer. Hum Pathol. 2006, 37: 989-999. 10.1016\/j.humpath.2006.04.013.","journal-title":"Hum Pathol"},{"key":"2419_CR9","doi-asserted-by":"publisher","first-page":"e1314","DOI":"10.1371\/journal.pone.0001314","volume":"2","author":"JM Ordway","year":"2007","unstructured":"Ordway JM, Budiman MA, Korshunova Y, Maloney RK, Bedell JA, Citek RW, Bacher B, Peterson S, Rohlfing T, Hall J, Brown R, Lakey N, Doerge RW, Martienssen RA, Leon J, McPherson JD, Jeddeloh JA: Identification of novel high-frequency DNA methylation changes in breast cancer. PLoS ONE. 2007, 2: e1314-10.1371\/journal.pone.0001314.","journal-title":"PLoS ONE"},{"key":"2419_CR10","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1093\/carcin\/bgn076","volume":"29","author":"J Veeck","year":"2008","unstructured":"Veeck J, Geisler C, Noetzel E, Alkaya S, Hartmann A, Knuchel R, Dahl E: Epigenetic inactivation of the Secreted frizzled-related protein-5 (SFRP5) gene in human breast cancer is associated with unfavorable prognosis. Carcinogenesis. 2008, 29: 991-998. 10.1093\/carcin\/bgn076.","journal-title":"Carcinogenesis"},{"key":"2419_CR11","first-page":"1087","volume":"12","author":"T Kobatake","year":"2004","unstructured":"Kobatake T, Yano M, Toyooka S, Tsukuda K, Dote H, Kikuchi T, Toyota M, Ouchida M, Aoe M, Date H, Pass HI, Doihara H, Shimizu N: Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas. Oncol Rep. 2004, 12: 1087-1092.","journal-title":"Oncol Rep"},{"key":"2419_CR12","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1002\/ijc.11508","volume":"107","author":"MJ Fackler","year":"2003","unstructured":"Fackler MJ, McVeigh M, Evron E, Garrett E, Mehrotra J, Polyak K, Sukumar S, Argani P: DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma. Int J Cancer. 2003, 107: 970-975. 10.1002\/ijc.11508.","journal-title":"Int J Cancer"},{"key":"2419_CR13","doi-asserted-by":"publisher","first-page":"R14","DOI":"10.1186\/bcr2233","volume":"11","author":"S Tommasi","year":"2009","unstructured":"Tommasi S, Karm DL, Wu X, Yen Y, Pfeifer GP: Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer. Breast Cancer Res. 2009, 11: R14-10.1186\/bcr2233.","journal-title":"Breast Cancer Res"},{"key":"2419_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S1535-6108(04)00023-6","volume":"5","author":"YG Crawford","year":"2004","unstructured":"Crawford YG, Gauthier ML, Joubel A, Mantei K, Kozakiewicz K, Afshari CA, Tlsty TD: Histologically normal human mammary epithelia with silenced p16(INK4a) overexpress COX-2, promoting a premalignant program. Cancer Cell. 2004, 5: 263-273. 10.1016\/S1535-6108(04)00023-6.","journal-title":"Cancer Cell"},{"key":"2419_CR15","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/35054579","volume":"409","author":"SR Romanov","year":"2001","unstructured":"Romanov SR, Kozakiewicz BK, Holst CR, Stampfer MR, Haupt LM, Tlsty TD: Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature. 2001, 409: 633-637. 10.1038\/35054579.","journal-title":"Nature"},{"key":"2419_CR16","doi-asserted-by":"publisher","first-page":"24790","DOI":"10.1074\/jbc.M604175200","volume":"281","author":"PA Reynolds","year":"2006","unstructured":"Reynolds PA, Sigaroudinia M, Zardo G, Wilson MB, Benton GM, Miller CJ, Hong C, Fridlyand J, Costello JF, Tlsty TD: Tumor suppressor p16INK4A regulates polycomb-mediated DNA hypermethylation in human mammary epithelial cells. J Biol Chem. 2006, 281: 24790-24802. 10.1074\/jbc.M604175200.","journal-title":"J Biol Chem"},{"key":"2419_CR17","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1371\/journal.pbio.0040051","volume":"4","author":"KM McDermott","year":"2006","unstructured":"McDermott KM, Zhang J, Holst CR, Kozakiewicz BK, Singla V, Tlsty TD: p16(INK4a) prevents centrosome dysfunction and genomic instability in primary cells. PLoS Biol. 2006, 4: e51-10.1371\/journal.pbio.0040051.","journal-title":"PLoS Biol"},{"key":"2419_CR18","first-page":"1596","volume":"63","author":"CR Holst","year":"2003","unstructured":"Holst CR, Nuovo GJ, Esteller M, Chew K, Baylin SB, Herman JG, Tlsty TD: Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia. Cancer Res. 2003, 63: 1596-1601.","journal-title":"Cancer Res"},{"key":"2419_CR19","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1158\/0008-5472.CAN-04-3507","volume":"65","author":"ML Gauthier","year":"2005","unstructured":"Gauthier ML, Pickering CR, Miller CJ, Fordyce CA, Chew KL, Berman HK, Tlsty TD: p38 regulates cyclooxygenase-2 in human mammary epithelial cells and is activated in premalignant tissue. Cancer Res. 2005, 65: 1792-1799. 10.1158\/0008-5472.CAN-04-3507.","journal-title":"Cancer Res"},{"key":"2419_CR20","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0092-8674(00)81902-9","volume":"88","author":"M Serrano","year":"1997","unstructured":"Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW: Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 1997, 88: 593-602. 10.1016\/S0092-8674(00)81902-9.","journal-title":"Cell"},{"key":"2419_CR21","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1073\/pnas.81.17.5435","volume":"81","author":"SL Hammond","year":"1984","unstructured":"Hammond SL, Ham RG, Stampfer MR: Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract. Proc Natl Acad Sci USA. 1984, 81: 5435-5439. 10.1073\/pnas.81.17.5435.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2419_CR22","doi-asserted-by":"publisher","first-page":"9821","DOI":"10.1073\/pnas.93.18.9821","volume":"93","author":"JG Herman","year":"1996","unstructured":"Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA. 1996, 93: 9821-9826. 10.1073\/pnas.93.18.9821.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2419_CR23","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.cccn.2004.07.006","volume":"349","author":"Y Gao","year":"2004","unstructured":"Gao Y, Guan M, Su B, Liu W, Xu M, Lu Y: Hypermethylation of the RASSF1A gene in gliomas. Clin Chim Acta. 2004, 349: 173-179. 10.1016\/j.cccn.2004.07.006.","journal-title":"Clin Chim Acta"},{"key":"2419_CR24","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/sj.bjc.6604259","volume":"98","author":"H Suzuki","year":"2008","unstructured":"Suzuki H, Toyota M, Caraway H, Gabrielson E, Ohmura T, Fujikane T, Nishikawa N, Sogabe Y, Nojima M, Sonoda T, Mori M, Hirata K, Imai K, Shinomura Y, Baylin SB, Tokino T: Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer. Br J Cancer. 2008, 98: 1147-1156. 10.1038\/sj.bjc.6604259.","journal-title":"Br J Cancer"},{"key":"2419_CR25","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1158\/1078-0432.1203.11.3","volume":"11","author":"Z Petko","year":"2005","unstructured":"Petko Z, Ghiassi M, Shuber A, Gorham J, Smalley W, Washington MK, Schultenover S, Gautam S, Markowitz SD, Grady WM: Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps. Clin Cancer Res. 2005, 11: 1203-1209.","journal-title":"Clin Cancer Res"},{"key":"2419_CR26","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/j.1464-410X.2008.07603.x","volume":"102","author":"D Guerrero","year":"2008","unstructured":"Guerrero D, Guarch R, Ojer A, Casas JM, Ropero S, Mancha A, Pesce C, Lloveras B, Garcia-Bragado F, Puras A: Hypermethylation of the thrombospondin-1 gene is associated with poor prognosis in penile squamous cell carcinoma. BJU Int. 2008, 102: 747-755. 10.1111\/j.1464-410X.2008.07603.x.","journal-title":"BJU Int"},{"key":"2419_CR27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/bcr1275","volume":"7","author":"G Dimri","year":"2005","unstructured":"Dimri G, Band H, Band V: Mammary epithelial cell transformation: insights from cell culture and mouse models. Breast Cancer Res. 2005, 7: 171-179. 10.1186\/bcr1275.","journal-title":"Breast Cancer Res"},{"key":"2419_CR28","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1101\/gad.828901","volume":"15","author":"B Elenbaas","year":"2001","unstructured":"Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, Donaher JL, Popescu NC, Hahn WC, Weinberg RA: Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev. 2001, 15: 50-65. 10.1101\/gad.828901.","journal-title":"Genes Dev"},{"key":"2419_CR29","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","volume":"121","author":"A Orimo","year":"2005","unstructured":"Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA: Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion. Cell. 2005, 121: 335-348. 10.1016\/j.cell.2005.02.034.","journal-title":"Cell"},{"key":"2419_CR30","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.1371\/journal.pbio.0020007","volume":"2","author":"HY Chang","year":"2004","unstructured":"Chang HY, Sneddon JB, Alizadeh AA, Sood R, West RB, Montgomery K, Chi JT, Rijn van de M, Botstein D, Brown PO: Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol. 2004, 2: E7-10.1371\/journal.pbio.0020007.","journal-title":"PLoS Biol"},{"key":"2419_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ccr.2004.07.009","volume":"6","author":"A Rangarajan","year":"2004","unstructured":"Rangarajan A, Hong SJ, Gifford A, Weinberg RA: Species- and cell type-specific requirements for cellular transformation. Cancer Cell. 2004, 6: 171-183. 10.1016\/j.ccr.2004.07.009.","journal-title":"Cancer Cell"},{"key":"2419_CR32","doi-asserted-by":"publisher","first-page":"7897","DOI":"10.1038\/sj.onc.1205902","volume":"21","author":"BS Herbert","year":"2002","unstructured":"Herbert BS, Wright WE, Shay JW: p16(INK4a) inactivation is not required to immortalize human mammary epithelial cells. Oncogene. 2002, 21: 7897-7900. 10.1038\/sj.onc.1205902.","journal-title":"Oncogene"},{"key":"2419_CR33","first-page":"6075","volume":"50","author":"HD Soule","year":"1990","unstructured":"Soule HD, Maloney TM, Wolman SR, Peterson WD, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF, Brooks SC: Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 1990, 50: 6075-6086.","journal-title":"Cancer Res"},{"key":"2419_CR34","first-page":"8135","volume":"61","author":"SW Hayward","year":"2001","unstructured":"Hayward SW, Wang Y, Cao M, Hom YK, Zhang B, Grossfeld GD, Sudilovsky D, Cunha GR: Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Res. 2001, 61: 8135-8142.","journal-title":"Cancer Res"},{"key":"2419_CR35","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1002\/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0.CO;2-A","volume":"55","author":"DL Page","year":"1985","unstructured":"Page DL, Dupont WD, Rogers LW, Rados MS: Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer. 1985, 55: 2698-2708. 10.1002\/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0.CO;2-A.","journal-title":"Cancer"},{"key":"2419_CR36","volume-title":"Cancer Res","author":"S Thaler","year":"2009","unstructured":"Thaler S, Hahnel PS, Schad A, Dammann R, Schuler M: RASSF1A Mediates p21Cip1\/Waf1-Dependent Cell Cycle Arrest and Senescence through Modulation of the Raf-MEK-ERK Pathway and Inhibition of Akt. Cancer Res. 2009"},{"key":"2419_CR37","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1128\/MCB.22.12.4309-4318.2002","volume":"22","author":"L Shivakumar","year":"2002","unstructured":"Shivakumar L, Minna J, Sakamaki T, Pestell R, White MA: The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol. 2002, 22: 4309-4318. 10.1128\/MCB.22.12.4309-4318.2002.","journal-title":"Mol Cell Biol"},{"key":"2419_CR38","first-page":"275","volume":"26","author":"L Liu","year":"2005","unstructured":"Liu L, Zhang J, Bates S, Li JJ, Peehl DM, Rhim JS, Pfeifer GP: A methylation profile of in vitro immortalized human cell lines. Int J Oncol. 2005, 26: 275-285.","journal-title":"Int J Oncol"},{"key":"2419_CR39","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1158\/0008-5472.92.65.1","volume":"65","author":"S Tommasi","year":"2005","unstructured":"Tommasi S, Dammann R, Zhang Z, Wang Y, Liu L, Tsark WM, Wilczynski SP, Li J, You M, Pfeifer GP: Tumor susceptibility of Rassf1a knockout mice. Cancer Res. 2005, 65: 92-98.","journal-title":"Cancer Res"},{"key":"2419_CR40","doi-asserted-by":"publisher","first-page":"281","DOI":"10.4161\/cbt.5.3.2384","volume":"5","author":"PK Lo","year":"2006","unstructured":"Lo PK, Mehrotra J, D'Costa A, Fackler MJ, Garrett-Mayer E, Argani P, Sukumar S: Epigenetic suppression of secreted frizzled related protein 1 (SFRP1) expression in human breast cancer. Cancer Biol Ther. 2006, 5: 281-286.","journal-title":"Cancer Biol Ther"},{"key":"2419_CR41","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.yexmp.2007.03.008","volume":"83","author":"AG Rivenbark","year":"2007","unstructured":"Rivenbark AG, Livasy CA, Boyd CE, Keppler D, Coleman WB: Methylation-dependent silencing of CST6 in primary human breast tumors and metastatic lesions. Exp Mol Pathol. 2007, 83: 188-197. 10.1016\/j.yexmp.2007.03.008.","journal-title":"Exp Mol Pathol"},{"key":"2419_CR42","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1158\/1055-9965.EPI-08-0472","volume":"17","author":"EH Gort","year":"2008","unstructured":"Gort EH, Suijkerbuijk KP, Roothaan SM, Raman V, Vooijs M, Wall van der E, van Diest PJ: Methylation of the TWIST1 promoter, TWIST1 mRNA levels, and immunohistochemical expression of TWIST1 in breast cancer. Cancer Epidemiol Biomarkers Prev. 2008, 17: 3325-3330. 10.1158\/1055-9965.EPI-08-0472.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2419_CR43","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1158\/1078-0432.CCR-03-0118","volume":"10","author":"J Mehrotra","year":"2004","unstructured":"Mehrotra J, Vali M, McVeigh M, Kominsky SL, Fackler MJ, Lahti-Domenici J, Polyak K, Sacchi N, Garrett-Mayer E, Argani P, Sukumar S: Very high frequency of hypermethylated genes in breast cancer metastasis to the bone, brain, and lung. Clin Cancer Res. 2004, 10: 3104-3109. 10.1158\/1078-0432.CCR-03-0118.","journal-title":"Clin Cancer Res"},{"key":"2419_CR44","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1126\/science.1136352","volume":"315","author":"A Hellman","year":"2007","unstructured":"Hellman A, Chess A: Gene body-specific methylation on the active X chromosome. Science. 2007, 315: 1141-1143. 10.1126\/science.1136352.","journal-title":"Science"},{"key":"2419_CR45","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1371\/journal.pbio.0060022","volume":"6","author":"R Illingworth","year":"2008","unstructured":"Illingworth R, Kerr A, Desousa D, Jorgensen H, Ellis P, Stalker J, Jackson D, Clee C, Plumb R, Rogers J, Humphray S, Cox T, Langford C, Bird A: A novel CpG island set identifies tissue-specific methylation at developmental gene loci. PLoS Biol. 2008, 6: e22-10.1371\/journal.pbio.0060022.","journal-title":"PLoS Biol"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr2457.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/bcr2457\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr2457.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:53:48Z","timestamp":1728384828000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr2457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,8]]},"references-count":45,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2009,12]]}},"alternative-id":["2419"],"URL":"https:\/\/doi.org\/10.1186\/bcr2457","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,8]]},"assertion":[{"value":"16 July 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R87"}}